Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $747.02 million. The enterprise value is $504.09 million.

Market Cap	747.02M
Enterprise Value	504.09M

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CMPX has 177.86 million shares outstanding. The number of shares has increased by 8.16% in one year.

Current Share Class	177.86M
Shares Outstanding	177.86M
Shares Change (YoY)	+8.16%
Shares Change (QoQ)	+22.06%
Owned by Insiders (%)	7.91%
Owned by Institutions (%)	47.73%
Float	120.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.39
P/TBV Ratio	3.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.82, with a Debt / Equity ratio of 0.05.

Current Ratio	17.82
Quick Ratio	17.72
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -37.82% and return on invested capital (ROIC) is -24.48%.

Return on Equity (ROE)	-37.82%
Return on Assets (ROA)	-23.47%
Return on Invested Capital (ROIC)	-24.48%
Return on Capital Employed (ROCE)	-32.64%
Revenue Per Employee	n/a
Profits Per Employee	-$1.88M
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +121.86% in the last 52 weeks. The beta is 1.30, so CMPX's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+121.86%
50-Day Moving Average	3.77
200-Day Moving Average	2.86
Relative Strength Index (RSI)	55.37
Average Volume (20 Days)	1,707,183

Short Selling Information

The latest short interest is 15.36 million, so 8.64% of the outstanding shares have been sold short.

Short Interest	15.36M
Short Previous Month	14.82M
Short % of Shares Out	8.64%
Short % of Float	12.76%
Short Ratio (days to cover)	8.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-71.42M
Pretax Income	-65.81M
Net Income	-65.81M
EBITDA	-71.02M
EBIT	-71.42M
Earnings Per Share (EPS)	-$0.45

Balance Sheet

The company has $219.90 million in cash and $9.87 million in debt, giving a net cash position of $210.03 million or $1.18 per share.

Cash & Cash Equivalents	219.90M
Total Debt	9.87M
Net Cash	210.03M
Net Cash Per Share	$1.18
Equity (Book Value)	209.61M
Book Value Per Share	1.18
Working Capital	208.71M

Cash Flow

In the last 12 months, operating cash flow was -$45.05 million and capital expenditures -$25,000, giving a free cash flow of -$45.08 million.

Operating Cash Flow	-45.05M
Capital Expenditures	-25,000
Free Cash Flow	-45.08M
FCF Per Share	-$0.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.16%
Shareholder Yield	-8.16%
Earnings Yield	-9.22%
FCF Yield	-6.31%

Analyst Forecast

The average price target for CMPX is $14.43, which is 243.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.43
Price Target Difference	243.57%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	236.43%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CMPX has an Altman Z-Score of 7.09 and a Piotroski F-Score of 1.

Altman Z-Score	7.09
Piotroski F-Score	1